Dave Holt

A partner in Potter Clarkson’s litigation and licensing team, Dave specialises in non-contentious intellectual property law, with historic experience in significant contentious patent matters. He specialises in the biotechnology, synthetic biology and cancer therapeutics sectors, with a major part of his practice focussing on novel therapeutics. Dave leads on IP Due Diligence services within Potter Clarkson as a core part of his practice, managing IP Due Diligence projects on behalf of investor clients, bringing together and co-ordinating multi-disciplinary teams of patent, design and trade mark experts.  

Dave also has substantial experience in drafting complex, multi-jurisdictional agreements including licensing arrangements, research and development agreements and collaboration agreements, as well as providing commercially focussed IP strategy advice for his clients.  This IP strategy advice particularly includes undertaking audits for clients advising on trade secret protection, policy and key terms in agreements.

Prior to joining Potter Clarkson in April 2018, Dave trained and qualified at a leading national law firm before spending a period as Assistant General Counsel at Unidays Ltd - the world’s largest student affinity network, managing its IP portfolio, agreements and international expansion.